Document is current
Any future updates will be listed below
-
Authors
Li, Yingchen
Yin, Linan
Liu, Bowen
Liu, Yan
He, Dongfeng
Liu, Xuesong
Liu, Ruibao
-
Funding
Funding for this research was provided by:
Nn10 Excellent Discipline Construction Program (No. Hepatobiliary and Pancreatic Tumor 2017, No. Hepatobiliary and Pancreatic Tumor 2017, No. Hepatobiliary and Pancreatic Tumor 2017, No. Hepatobiliary and Pancreatic Tumor 2017, No. Hepatobiliary and Pancreatic Tumor 2017, No. Hepatobiliary and Pancreatic Tumor 2017, No. Hepatobiliary and Pancreatic Tumor 2017)
- License Information
-
More Information
Article History
Received: 2 November 2024
Accepted: 17 February 2025
First Online: 25 February 2025
Declarations
:
: Not applicable.All experiments in this study were conducted using commercially available cell lines (or cell lines without specific ethical concerns) and did not involve human subjects or animal testing. Therefore, ethical approval was not required for this study.
: Not applicable.
: The authors declare no competing interests.
